LESPRONA
LIVE

Serial Number

79186797

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 5, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LESPRONA Trademark

Serial Number: 79186797 • Registration: 5070799

LESPRONA is a trademark filed by NOVARTIS AG on February 5, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 5, 2016

Registration Date

November 1, 2016

Published for Opposition

August 16, 2016

Cancellation Date

October 17, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 1, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 1, 2019 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 17, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 24, 2017 FICS
FINAL DISPOSITION PROCESSED
Feb 24, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 1, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 1, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 16, 2016 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2016 NPUB
PUBLISHED FOR OPPOSITION
Aug 16, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 10, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 10, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 27, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 5, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 5, 2016 REAP
REFUSAL PROCESSED BY IB
Jun 10, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 24, 2016 RFCS
REFUSAL PROCESSED BY MPU
May 24, 2016 RFRR
APPLICATION FILING RECEIPT MAILED
May 24, 2016 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 23, 2016 RFCR
NON-FINAL ACTION WRITTEN
May 22, 2016 CNRT
ASSIGNED TO EXAMINER
May 20, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 19, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 19, 2016 REPR